Home › Lung Diseases › Indiana
Lung Diseases clinical trials in Indiana
5 studies for Lung Diseases are looking for participants at sites in Indiana.
Cities in Indiana
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- St. Vincent Health, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.